ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Sun Pharma Advanced Research Company submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report detailing ESG initiatives forms part of the Annual Report.
SPARC's partner Ocuvex received a US FDA Complete Response Letter for the PDP-716 drug application. The FDA cited manufacturing inspection findings but raised no other issues.